BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haj-Dahmane S, Shen RY. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J Neurosci 2005;25:896-905. [PMID: 15673670 DOI: 10.1523/JNEUROSCI.3258-04.2005] [Cited by in Crossref: 96] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I, Deutsch DG. Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs. PLoS One 2012;7:e50968. [PMID: 23236415 DOI: 10.1371/journal.pone.0050968] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 9.3] [Reference Citation Analysis]
2 Donovan MH, Tecott LH. Serotonin and the regulation of mammalian energy balance. Front Neurosci 2013;7:36. [PMID: 23543912 DOI: 10.3389/fnins.2013.00036] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
3 Bambico FR, Katz N, Debonnel G, Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 2007;27:11700-11. [PMID: 17959812 DOI: 10.1523/JNEUROSCI.1636-07.2007] [Cited by in Crossref: 205] [Cited by in F6Publishing: 78] [Article Influence: 13.7] [Reference Citation Analysis]
4 Thompson MD, Xhaard H, Sakurai T, Rainero I, Kukkonen JP. OX1 and OX2 orexin/hypocretin receptor pharmacogenetics. Front Neurosci 2014;8:57. [PMID: 24834023 DOI: 10.3389/fnins.2014.00057] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
5 Ishibashi M, Gumenchuk I, Miyazaki K, Inoue T, Ross WN, Leonard CS. Hypocretin/Orexin Peptides Alter Spike Encoding by Serotonergic Dorsal Raphe Neurons through Two Distinct Mechanisms That Increase the Late Afterhyperpolarization. J Neurosci 2016;36:10097-115. [PMID: 27683906 DOI: 10.1523/JNEUROSCI.0635-16.2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
6 Wenzel JM, Cheer JF. Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues. Front Psychiatry 2014;5:118. [PMID: 25225488 DOI: 10.3389/fpsyt.2014.00118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
7 Xiao X, Yeghiazaryan G, Hess S, Klemm P, Sieben A, Kleinridders A, Morgan DA, Wunderlich FT, Rahmouni K, Kong D, Scammell TE, Lowell BB, Kloppenburg P, Brüning JC, Hausen AC. Orexin receptors 1 and 2 in serotonergic neurons differentially regulate peripheral glucose metabolism in obesity. Nat Commun 2021;12:5249. [PMID: 34475397 DOI: 10.1038/s41467-021-25380-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Katona I, Freund TF. Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci 2012;35:529-58. [PMID: 22524785 DOI: 10.1146/annurev-neuro-062111-150420] [Cited by in Crossref: 335] [Cited by in F6Publishing: 320] [Article Influence: 33.5] [Reference Citation Analysis]
9 Heinbockel T, Straiker A. Cannabinoids Regulate Sensory Processing in Early Olfactory and Visual Neural Circuits. Front Neural Circuits 2021;15:662349. [PMID: 34305536 DOI: 10.3389/fncir.2021.662349] [Reference Citation Analysis]
10 Hashimotodani Y, Ohno-Shosaku T, Tanimura A, Kita Y, Sano Y, Shimizu T, Di Marzo V, Kano M. Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde signalling: evidence for on-demand biosynthesis of 2-arachidonoylglycerol. J Physiol 2013;591:4765-76. [PMID: 23858009 DOI: 10.1113/jphysiol.2013.254474] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
11 Straiker A, Dvorakova M, Zimmowitch A, Mackie K. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons. Mol Pharmacol 2018;94:743-8. [PMID: 29669714 DOI: 10.1124/mol.118.111864] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
12 Maejima T, Masseck OA, Mark MD, Herlitze S. Modulation of firing and synaptic transmission of serotonergic neurons by intrinsic G protein-coupled receptors and ion channels. Front Integr Neurosci 2013;7:40. [PMID: 23734105 DOI: 10.3389/fnint.2013.00040] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
13 Kangarlu-Haghighi K, Oryan S, Nasehi M, Zarrindast MR. The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA. EXCLI J 2015;14:613-26. [PMID: 26648818 DOI: 10.17179/excli2015-201] [Reference Citation Analysis]
14 Haj-Dahmane S, Shen RY. Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons. J Physiol 2010;588:2589-604. [PMID: 20498231 DOI: 10.1113/jphysiol.2010.190066] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
15 Häring M, Enk V, Aparisi Rey A, Loch S, Ruiz de Azua I, Weber T, Bartsch D, Monory K, Lutz B. Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability. Front Behav Neurosci 2015;9:235. [PMID: 26388750 DOI: 10.3389/fnbeh.2015.00235] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
16 Mendiguren A, Aostri E, Pineda J. Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence. Adv Exp Med Biol 2021;1297:111-32. [PMID: 33537940 DOI: 10.1007/978-3-030-61663-2_8] [Reference Citation Analysis]
17 Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? Br J Pharmacol 2010;160:530-43. [PMID: 20590563 DOI: 10.1111/j.1476-5381.2010.00790.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 7.3] [Reference Citation Analysis]
18 Wang J, Shen RY, Haj-Dahmane S. Endocannabinoids mediate the glucocorticoid-induced inhibition of excitatory synaptic transmission to dorsal raphe serotonin neurons. J Physiol 2012;590:5795-808. [PMID: 22946098 DOI: 10.1113/jphysiol.2012.238659] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
19 Regehr WG, Carey MR, Best AR. Activity-dependent regulation of synapses by retrograde messengers. Neuron 2009;63:154-70. [PMID: 19640475 DOI: 10.1016/j.neuron.2009.06.021] [Cited by in Crossref: 157] [Cited by in F6Publishing: 163] [Article Influence: 12.1] [Reference Citation Analysis]
20 Heifets BD, Castillo PE. Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol 2009;71:283-306. [PMID: 19575681 DOI: 10.1146/annurev.physiol.010908.163149] [Cited by in Crossref: 285] [Cited by in F6Publishing: 298] [Article Influence: 21.9] [Reference Citation Analysis]
21 Hashimotodani Y, Ohno-Shosaku T, Watanabe M, Kano M. Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release. J Physiol 2007;584:373-80. [PMID: 17615097 DOI: 10.1113/jphysiol.2007.137497] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
22 Patel S, Hillard CJ. Role of endocannabinoid signaling in anxiety and depression. Curr Top Behav Neurosci 2009;1:347-71. [PMID: 21104391 DOI: 10.1007/978-3-540-88955-7_14] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
23 Wyrofsky R, McGonigle P, Van Bockstaele EJ. Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease. Expert Opin Drug Discov 2015;10:17-36. [PMID: 25488672 DOI: 10.1517/17460441.2014.966680] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
24 Haj-Dahmane S, Shen RY. Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors. J Pharmacol Exp Ther 2009;331:186-96. [PMID: 19592666 DOI: 10.1124/jpet.109.153858] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
25 Gyombolai P, Pap D, Turu G, Catt KJ, Bagdy G, Hunyady L. Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action. Mol Cell Endocrinol 2012;353:29-36. [PMID: 22075205 DOI: 10.1016/j.mce.2011.10.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
26 Ho YC, Lee HJ, Tung LW, Liao YY, Fu SY, Teng SF, Liao HT, Mackie K, Chiou LC. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition. J Neurosci 2011;31:14600-10. [PMID: 21994376 DOI: 10.1523/JNEUROSCI.2671-11.2011] [Cited by in Crossref: 105] [Cited by in F6Publishing: 48] [Article Influence: 9.5] [Reference Citation Analysis]
27 Zhao Y, Tzounopoulos T. Physiological activation of cholinergic inputs controls associative synaptic plasticity via modulation of endocannabinoid signaling. J Neurosci 2011;31:3158-68. [PMID: 21368027 DOI: 10.1523/JNEUROSCI.5303-10.2011] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
28 Kukkonen JP, Leonard CS. Orexin/hypocretin receptor signalling cascades. Br J Pharmacol 2014;171:314-31. [PMID: 23902572 DOI: 10.1111/bph.12324] [Cited by in Crossref: 104] [Cited by in F6Publishing: 91] [Article Influence: 13.0] [Reference Citation Analysis]
29 Mieda M, Tsujino N, Sakurai T. Differential roles of orexin receptors in the regulation of sleep/wakefulness. Front Endocrinol (Lausanne) 2013;4:57. [PMID: 23730297 DOI: 10.3389/fendo.2013.00057] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
30 Schöne C, Burdakov D. Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain. Curr Top Behav Neurosci 2017;33:51-74. [PMID: 27830577 DOI: 10.1007/7854_2016_45] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
31 Haj-Dahmane S, Béïque JC, Shen RY. GluA2-Lacking AMPA Receptors and Nitric Oxide Signaling Gate Spike-Timing-Dependent Potentiation of Glutamate Synapses in the Dorsal Raphe Nucleus. eNeuro 2017;4:ENEURO. [PMID: 28580416 DOI: 10.1523/ENEURO.0116-17.2017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
32 Haj-Dahmane S, Shen RY. Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology 2011;61:414-20. [PMID: 21354188 DOI: 10.1016/j.neuropharm.2011.02.016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
33 Viveros MP, Bermúdez-Silva FJ, Lopez-Rodriguez AB, Wagner EJ. The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. Pharmaceuticals (Basel) 2011;4:1101-36. [PMID: 32143540 DOI: 10.3390/ph4081101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Wang H, Lupica CR. Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes. Prog Neuropsychopharmacol Biol Psychiatry 2014;52:24-7. [PMID: 24495779 DOI: 10.1016/j.pnpbp.2014.01.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
35 Haj-Dahmane S, Shen RY. Chronic stress impairs α1-adrenoceptor-induced endocannabinoid-dependent synaptic plasticity in the dorsal raphe nucleus. J Neurosci 2014;34:14560-70. [PMID: 25355210 DOI: 10.1523/JNEUROSCI.1310-14.2014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
36 Cachope R. Functional diversity on synaptic plasticity mediated by endocannabinoids. Philos Trans R Soc Lond B Biol Sci 2012;367:3242-53. [PMID: 23108543 DOI: 10.1098/rstb.2011.0386] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
37 Alexander C, Vasefi M. Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder. IBRO Neuroscience Reports 2021;11:88-102. [DOI: 10.1016/j.ibneur.2021.08.001] [Reference Citation Analysis]
38 Béïque JC, Imad M, Mladenovic L, Gingrich JA, Andrade R. Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc Natl Acad Sci U S A 2007;104:9870-5. [PMID: 17535909 DOI: 10.1073/pnas.0700436104] [Cited by in Crossref: 128] [Cited by in F6Publishing: 125] [Article Influence: 8.5] [Reference Citation Analysis]
39 Alger BE, Kim J. Supply and demand for endocannabinoids. Trends Neurosci 2011;34:304-15. [PMID: 21507493 DOI: 10.1016/j.tins.2011.03.003] [Cited by in Crossref: 169] [Cited by in F6Publishing: 158] [Article Influence: 15.4] [Reference Citation Analysis]
40 Jacobson LH, Commerford SR, Gerber SP, Chen YA, Dardik B, Chaperon F, Schwartzkopf C, Nguyen-Tran V, Hollenbeck T, McNamara P, He X, Liu H, Seidel HM, Jaton AL, Gromada J, Teixeira S. Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity. Naunyn Schmiedebergs Arch Pharmacol 2011;384:565-81. [PMID: 21947251 DOI: 10.1007/s00210-011-0686-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
41 Lee SH, Földy C, Soltesz I. Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J Neurosci 2010;30:7993-8000. [PMID: 20534847 DOI: 10.1523/JNEUROSCI.6238-09.2010] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 6.4] [Reference Citation Analysis]
42 Flores A, Maldonado R, Berrendero F. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci 2013;7:256. [PMID: 24391536 DOI: 10.3389/fnins.2013.00256] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
43 Hillard CJ, Liu QS. Endocannabinoid signaling in the etiology and treatment of major depressive illness. Curr Pharm Des. 2014;20:3795-3811. [PMID: 24180398 DOI: 10.2174/13816128113196660735] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
44 Leonard CS, Kukkonen JP. Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol 2014;171:294-313. [PMID: 23848055 DOI: 10.1111/bph.12296] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
45 Mendiguren A, Pineda J. Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices. Br J Pharmacol 2009;158:1579-87. [PMID: 19845674 DOI: 10.1111/j.1476-5381.2009.00434.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
46 Thompson MD, Sakurai T, Rainero I, Maj MC, Kukkonen JP. Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics. Pharmaceuticals (Basel) 2017;10:E79. [PMID: 28991183 DOI: 10.3390/ph10040079] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
47 Oubraim S, Wang R, Hausknecht KA, Shen RY, Haj-Dahmane S. Tonic Endocannabinoid Signaling Gates Synaptic Plasticity in Dorsal Raphe Nucleus Serotonin Neurons Through Peroxisome Proliferator-Activated Receptors. Front Pharmacol 2021;12:691219. [PMID: 34262460 DOI: 10.3389/fphar.2021.691219] [Reference Citation Analysis]
48 Kano M. Control of synaptic function by endocannabinoid-mediated retrograde signaling. Proc Jpn Acad Ser B Phys Biol Sci 2014;90:235-50. [PMID: 25169670 DOI: 10.2183/pjab.90.235] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 9.6] [Reference Citation Analysis]
49 Haj-Dahmane S, Shen RY, Elmes MW, Studholme K, Kanjiya MP, Bogdan D, Thanos PK, Miyauchi JT, Tsirka SE, Deutsch DG, Kaczocha M. Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses. Proc Natl Acad Sci U S A 2018;115:3482-7. [PMID: 29531087 DOI: 10.1073/pnas.1721339115] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
50 Cristino L, Palomba L, Di Marzo V. New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolism. Int J Obes Suppl 2014;4:S26-30. [PMID: 27152162 DOI: 10.1038/ijosup.2014.8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
51 Crawford LK, Craige CP, Beck SG. Glutamatergic input is selectively increased in dorsal raphe subfield 5-HT neurons: role of morphology, topography and selective innervation. Eur J Neurosci 2011;34:1794-806. [PMID: 22098248 DOI: 10.1111/j.1460-9568.2011.07882.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kohlmeier KA, Tyler CJ, Kalogiannis M, Ishibashi M, Kristensen MP, Gumenchuk I, Chemelli RM, Kisanuki YY, Yanagisawa M, Leonard CS. Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy. Front Neurosci 2013;7:246. [PMID: 24391530 DOI: 10.3389/fnins.2013.00246] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
53 Hashimotodani Y, Ohno-Shosaku T, Yamazaki M, Sakimura K, Kano M. Neuronal protease-activated receptor 1 drives synaptic retrograde signaling mediated by the endocannabinoid 2-arachidonoylglycerol. J Neurosci 2011;31:3104-9. [PMID: 21414931 DOI: 10.1523/JNEUROSCI.6000-10.2011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
54 Kaul M, Zee PC, Sahni AS. Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders. Neurotherapeutics 2021;18:217-27. [PMID: 33580483 DOI: 10.1007/s13311-021-01013-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Lemos JC, Pan YZ, Ma X, Lamy C, Akanwa AC, Beck SG. Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe. Eur J Neurosci 2006;24:3415-30. [PMID: 17229091 DOI: 10.1111/j.1460-9568.2006.05222.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]